Modified Parkinson’s drug shows potential in treating nonalcoholic fatty liver disease

Modified Parkinson’s drug shows potential in treating nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by excessive fat accumulation in the liver. It can cause serious complications, including nonalcoholic steatohepatitis, cirrhosis and cancer. Although prevalent, there is a dearth of drugs to treat NAFLD, with current therapies revolving around lifestyle interventions. ... read more
Source: Medical XpressPublished on 2020-05-29